Dorman Products (NASDAQ: DORM) reported Q2 EPS of $3.08, $1.19 better than the analyst estimate of $1.89. Revenue for the quarter came in at $544.6 million versus the consensus estimate of $582.26 million.

GUIDANCE:

Dorman Products sees FY2026 EPS of $8.50-$8.80, versus the consensus of $8.28.

For earnings history and earnings-related data on Dorman Products (DORM) click here.